Dihydromyricetin activates AMP-activated protein kinase and P38(MAPK) exerting antitumor potential in osteosarcoma.
Zhao Z, Yin JQ, Wu MS, Song G, Xie XB, Zou C, Tang Q, Wu Y, Lu J, Wang Y, Wang J, Kang T, Jia Q, Shen J.
Zhao Z, et al. Among authors: jia q.
Cancer Prev Res (Phila). 2014 Sep;7(9):927-38. doi: 10.1158/1940-6207.CAPR-14-0067. Epub 2014 Jun 3.
Cancer Prev Res (Phila). 2014.
PMID: 24894198